Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· MindWhizBrosAudio: English

Video description: 72 adults 65+ in an 8-week MIND diet feeding trial; brain scans before and after

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

At a glance

Automatic summary · not editorially reviewed

The description reports a controlled 8-week feeding trial in 72 adults aged 65 and older with early cognitive decline: the MIND diet group scored higher on some memory and speed tests, and imaging showed a structurally younger fornix than in the control group, described as about 2.5 years of brain age reversed. The creator notes the mechanism is unexplained. [1]

  1. The description says the trial recruited 72 adults aged 65 and older with early cognitive decline; half received the MIND diet and the control group standard nutritional guidance, with all meals provided. [1]

  2. The description reports that the MIND group scored higher on episodic memory tasks and that processing speed increased, while imaging showed increased fractional anisotropy in the fornix and a structurally younger appearance than the control group's age-expected decline. [1]

  3. The creator states that neuroplasticity at that scale typically requires months, that eight weeks is the duration of most pharmaceutical trials failing to show structural change, and that the mechanism is not explained. [1]

72 adults 65+ with early cognitive decline

According to the description, the MIND diet trial recruited 72 adults aged 65 and older, all showing early cognitive decline. Half received the MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay): leafy greens six times weekly, berries twice, whole grains three times daily, olive oil as the primary fat. The control group received standard nutritional guidance. Every meal was provided, and compliance was monitored through food diaries and blood biomarkers. [1]

Memory scores and a younger-looking fornix at 8 weeks

The description says brain imaging captured hippocampal volume and white matter integrity at baseline, and scans were repeated eight weeks later. The first cognitive tests showed measurable separation: the MIND group scored higher on episodic memory tasks such as recalling word lists and face-name pairs, and processing speed increased. The anatomical finding was specific: diffusion tensor imaging showed increased fractional anisotropy in the fornix, the white matter tract connecting hippocampus to prefrontal cortex. The control group's fornix showed age-expected microstructural decline, while the MIND group's fornix appeared structurally younger. Researchers calculated the difference as two and a half years of biological brain age, reversed. Bloodwork confirmed elevated BDNF (brain-derived neurotrophic factor) in the intervention cohort. [1]

Creator flags unexplained mechanism and 8-week limit

The description itself raises a complication: neuroplasticity at that scale typically requires months of intervention, and eight weeks is the duration of most pharmaceutical trials that fail to show structural change. The creator says the resolution raises more questions than it answers, that the trial ended at eight weeks, and that the fornix imaging is public record while the mechanism is not. The description also promotes subscribing to the channel and lists sources including Rush University Medical Center MIND diet publications. [1]

Context & limits

This is based only on the video description; the video and transcript were not reviewed. The description gives no full methods, statistics, adverse events or longer-term outcomes, and the reported 2.5-year brain-age difference is the creator's summary of a single 8-week trial. The creator notes the mechanism is unexplained. Associations in one small trial are not proof of cause, and the description's promotional content is not evidence.

Based on the creator’s description; the full video and transcript were not analyzed.

[1] This Diet Slowed Brain Aging by 2.5 Years—The Files Show How #Shorts
Quoted passages in the original language
recruited seventy-two adults aged sixty-five and older
increased fractional anisotropy in the fornix
The mechanism is not

About this video

Creator description · original textText language: English

Seventy-two volunteers aged their brains at different speeds by eating differently. Seventy-two volunteers aged their brains at different speeds by eating differently. A diet slowed brain aging by two and a half years in one controlled trial. Seventy-two volunteers. Eight weeks of controlled feeding. Brain scans before and after. This is what the files documented. The MIND diet trial recruited seventy-two adults aged sixty-five and older, all showing early cognitive decline. Half received the Mediterranean-DASH Intervention for Neurodegenerative Delay diet—leafy greens six times weekly, berries twice, whole grains three times daily, olive oil as the primary fat. The control group received standard nutritional guidance. Every meal was provided. Compliance was monitored through food diaries and blood biomarkers. Brain imaging captured hippocampal volume and white matter integrity at baseline. Eight weeks later, the scans repeated. The first cognitive tests showed measurable separation. The MIND group scored higher on episodic memory tasks—recalling word lists, face-name pairs. Processing speed increased. But the anatomical finding was specific: diffusion tensor imaging showed increased fractional anisotropy in the fornix, the white matter tract connecting hippocampus to prefrontal cortex. The control group's fornix showed age-expected microstructural decline. The MIND group's fornix appeared structurally younger. Researchers calculated the difference: two and a half years of biological brain age, reversed. Bloodwork confirmed elevated BDNF—brain-derived neurotrophic factor—in the intervention cohort. But one detail complicated the mechanism. Neuroplasticity at that scale typically requires months of intervention. Eight weeks is the duration of most pharmaceutical trials that fail to show structural change. The resolution raises more questions than it answers. The trial ended at eight weeks. Two and a half years of brain age, reversed in eight weeks of eating. The fornix imaging is public record. The mechanism is not. Subscribe to @MindWhizBros for the next case file—the mind, demonstrated and documented. Subscribe @MindWhizBros for the next case Sources: • https://news.google.com/rss/articles/CBMib0FVX3lxTFBRMF9PQzBBNGxCTDN0VUJQQlJwS2xiLUFfM0N2TjBaeGF3QnRNNHBYZFVaRk4zby1JWThjLXRxbXU1WW1ydV90MVdPNGtUS1RDaXg5ZnVqbldiYTV0SXlGSFVoXzg4aklqVGNDZHRBaw • Rush University Medical Center MIND diet research publications Music: "Local Forecast" by Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 4.0 — https://creativecommons.org/licenses/by/4.0/ More from the WhizBros family: • @BrainyWhizBros — daily curiosity & science facts • @CashWhizBros — money psychology & financial literacy • @CosmicWhizBros — space discoveries & astronomy #Shorts #YouTubeShorts #MIND diet #brain aging #neuroplasticity #cognitive decline #nutrition science #hippocampus #white matter #BDNF #dementia prevention #Mediterranean diet #neuroscience #brain health

MindWhizBros · 2 min · Source published: 2026-10-03

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…